College of Bioengineering, Henan University of Technology, Zhengzhou, 450001, Henan, China.
Key Laboratory of Functional Molecules for Biomedical Research, Henan University of Technology, Zhengzhou, 450001, Henan, China.
J Nanobiotechnology. 2023 Nov 15;21(1):427. doi: 10.1186/s12951-023-02186-6.
Bacterial wound infections are a serious threat due to the emergence of antibiotic resistance. Herein, we report an innovative hybrid nanozyme independent of antibiotics for antimicrobial wound healing. The hybrid nanozymes are fabricated from ultra-small Au NPs via in-situ growth on metal-organic framework (MOF)-stabilised FeO NPs (FeO@MOF@Au NPs, FMA NPs). The fabricated hybrid nanozymes displayed synergistic peroxidase (POD)-like activities. It showed a remarkable level of hydroxyl radicals (·OH) in the presence of a low dose of HO (0.97 mM). Further, the hybrid FMA nanozymes exhibited excellent biocompatibility and favourable antibacterial effects against both Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) bacteria. The animal experiments indicated that the hybrid nanozymes promoted wound repair with adequate biosafety. Thus, the well-designed hybrid nanozymes represent a potential strategy for healing bacterial wound infections, without any toxic side effects, suggesting possible applications in antimicrobial therapy.
细菌引起的伤口感染是一个严重的威胁,因为抗生素耐药性的出现。在此,我们报告了一种创新的混合纳米酶,它不依赖抗生素,可用于抗菌伤口愈合。该混合纳米酶是通过在金属有机骨架(MOF)稳定的 FeO NPs(FeO@MOF@Au NPs,FMA NPs)上原位生长超小 Au NPs 制备的。所制备的混合纳米酶表现出协同过氧化物酶(POD)样活性。在低剂量 HO(0.97 mM)存在下,它显示出显著水平的羟基自由基(·OH)。此外,混合 FMA 纳米酶表现出良好的生物相容性和对革兰氏阴性(大肠杆菌)和革兰氏阳性(金黄色葡萄球菌)细菌的良好抗菌作用。动物实验表明,混合纳米酶具有足够的生物安全性,促进了伤口修复。因此,设计良好的混合纳米酶代表了一种治疗细菌感染性伤口的潜在策略,没有任何毒副作用,这表明它们可能在抗菌治疗中有应用前景。